1. Kimberly Raines. PBPK biopharmaceutics guidance and progress on risk assessment. Available at https://complexgenerics.org/media/SOP/complexgenerics/pdf/Conference-Slides/D2-04%20Kimberly%20Raines_PBPKGuidanceRiskAssessment.pdf. Accessed March 1, 2022.
2. Biopharmaceutic risk assessment of brand and generic lamotrigine tablets;Vaithianathan;Mol Pharmaceutics,2015
3. Food and Drug Administration. Guidance for industry: dissolution testing and acceptance criteria for immediate-release solid oral dosage form drug products containing high solubility drug substances. Available at: https://www.fda.gov/files/drugs/published/Dissolution-Testing-and-Acceptance-Criteria-for-Immediate-Release-Solid-Oral-Dosage-Form-Drug-Products-Containing-High-Solubility-Drug-Substances-Guidance-for-Industry.pdf. Accessed March 1, 2022.
4. On the usefulness of two small-scale in vitro setups in the evaluation of luminal precipitation of lipophilic weak bases in early formulation development;O'Dwyer;Pharmaceutics,2020
5. Simultaneous analysis of dissolution and permeation profiles of nanosized and microsized formulations of indomethacin using the in vitro dissolution absorption system 2;Li;J Pharm Sci,2019